PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.56%
Revenue growth at 50-75% of 3088.T's 6.81%. Martin Whitman would worry about competitiveness or product relevance.
2.69%
Gross profit growth under 50% of 3088.T's 5.46%. Michael Burry would be concerned about a severe competitive disadvantage.
5.94%
Positive EBIT growth while 3088.T is negative. John Neff might see a substantial edge in operational management.
0.67%
Operating income growth under 50% of 3088.T's 17.56%. Michael Burry would be concerned about deeper cost or sales issues.
-4.69%
Negative net income growth while 3088.T stands at 2.49%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.70%
Negative EPS growth while 3088.T is at 2.51%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.70%
Negative diluted EPS growth while 3088.T is at 2.46%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.03%
10Y revenue/share CAGR under 50% of 3088.T's 35.63%. Michael Burry would suspect a lasting competitive disadvantage.
-7.20%
Negative 5Y CAGR while 3088.T stands at 26.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.91%
Negative 3Y CAGR while 3088.T stands at 17.96%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
24.45%
Below 50% of 3088.T's 85.46%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.10%
Below 50% of 3088.T's 884.57%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-43.23%
Negative 3Y CAGR while 3088.T is 106.16%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
33.35%
5Y equity/share CAGR at 50-75% of 3088.T's 59.26%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-12.89%
Negative 3Y equity/share growth while 3088.T is at 40.21%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-99.40%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
0.08%
Inventory shrinking or stable vs. 3088.T's 1.43%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.93%
Similar asset growth to 3088.T's 1.86%. Walter Schloss finds parallel expansions or investment rates.
4.20%
BV/share growth above 1.5x 3088.T's 1.81%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-34.68%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
82.29%
SG&A growth well above 3088.T's 29.58%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.